However, our data showed that the PD-L1 promoter of breast cancer cells is in a DNA hypo-methylated status and that TET2 depletion does not alter the DNA methylation or hydroxymethylation levels at the promoter region of PD-L1 gene. The gene discussed is TET2; the disease is breast cancer.